Smith Group Asset Management, LLC
- SEC CIK
- 0001893134
- Latest filing
- Aug 3, 2026
CORT holding history
Corcept Therapeutics Inc in every 13F filed by Smith Group Asset Management, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
CORT overviewAll 13F holders of CORTFull Q2 2026 holdings
- Shares (Q1 2026)
- 0
- Sold out in Q1 2026
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 10
- Since Q3 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q1 2026 | 0 | $0 | 0.0% | −9,520−100.0% | Sold out | Holders |
| Q4 2025 | 9,520 | $331.3K | <0.1% | +225+2.4% | Added | Holders |
| Q3 2025 | 9,295 | $772.5K | <0.1% | +276+3.1% | Added | Holders |
| Q2 2025 | 9,019 | $662.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2025 | 9,019 | $1.03M | 0.1% | −6,389−41.5% | Reduced | Holders |
| Q4 2024 | 15,408 | $776.4K | 0.1% | +152+1.0% | Added | Holders |
| Q3 2024 | 15,256 | $706.0K | 0.1% | +3,081+25.3% | Added | Holders |
| Q2 2024 | 12,175 | $395.6K | <0.1% | +73+0.6% | Added | Holders |
| Q1 2024 | 12,102 | $304.8K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2023 | 12,102 | $393.1K | <0.1% | – | No prior filing | Holders |
| Q4 2021 | 0 | $0 | 0.0% | −27,422−100.0% | Sold out | Holders |
| Q3 2021 | 27,422 | $540.0K | <0.1% | – | No prior filing | Holders |